近期，在《健闻咨询》和Pivotal bioVenture China (碧沃投资本)管理合伙人柳丹博士对话中，他说道，“在饱和式创新的中国生态，一旦别人达成了前三、最多前五个交易，你就没机会了。” ...

The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping takeover valuations, trailblazing innovation in battling obesity and cancer, ...

So far in 2026, biotech deals amounted to $106 billion over 201 transactions, according to PitchBook data. That momentum in dealmaking comes despite an interest rate environment that has turned for ...

CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded ...

Lizzi C. Lee is a fellow on the Chinese economy at Asia Society Policy Institute’s Center for China Analysis (CCA), based in Washington DC, USA. Jing Qian is vice-president of the Asia Society and ...

CAMARILLO, Calif., July 21, 2026 /PRNewswire/ -- PBS Biotech, a leading developer of innovative single-use bioreactor technologies for cell therapy manufacturing, today announced it has been named ...

In a bold move to transform patient care, Rice University has launched RBL LLC, a pioneering biotech venture creation studio designed to rapidly build companies based on lifesaving medical ...

Ben McClure is a seasoned venture finance advisor with 10+ years of experience helping CEOs secure early-stage investments. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in ...

While the past couple of years featured record numbers of initial public offerings and capital raises for biotech startups, the mood has changed dramatically in 2022. There have only been a handful of ...